Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), a biotechnology company, focuses on discovering and developing therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. The company is currently building a pipeline of drugs that may be more effective and less toxic to healthy tissues than conventional drugs. Their staff consists of research scientists and business professionals with successful track records in the biotech industry. For further information, visit the Company’s web site at www.thresholdpharm.com.